chr4-38855689-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006068.5(TLR6):​c.-65+1072C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 151,922 control chromosomes in the GnomAD database, including 4,917 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4917 hom., cov: 31)

Consequence

TLR6
NM_006068.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00500

Publications

3 publications found
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006068.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR6
NM_006068.5
MANE Select
c.-65+1072C>T
intron
N/ANP_006059.2
TLR6
NM_001394553.1
c.-65+1999C>T
intron
N/ANP_001381482.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR6
ENST00000508254.6
TSL:1 MANE Select
c.-65+1072C>T
intron
N/AENSP00000424718.2
TLR6
ENST00000381950.2
TSL:6
c.-218+1072C>T
intron
N/AENSP00000371376.1
TLR1
ENST00000506146.5
TSL:4
c.-353+1072C>T
intron
N/AENSP00000423725.1

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36562
AN:
151804
Hom.:
4904
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.133
Gnomad SAS
AF:
0.148
Gnomad FIN
AF:
0.374
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.204
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.241
AC:
36609
AN:
151922
Hom.:
4917
Cov.:
31
AF XY:
0.238
AC XY:
17664
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.215
AC:
8903
AN:
41416
American (AMR)
AF:
0.120
AC:
1836
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
626
AN:
3466
East Asian (EAS)
AF:
0.134
AC:
694
AN:
5182
South Asian (SAS)
AF:
0.148
AC:
712
AN:
4812
European-Finnish (FIN)
AF:
0.374
AC:
3931
AN:
10508
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.283
AC:
19262
AN:
67952
Other (OTH)
AF:
0.209
AC:
440
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1342
2685
4027
5370
6712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
20604
Bravo
AF:
0.220
Asia WGS
AF:
0.192
AC:
667
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.0
DANN
Benign
0.30
PhyloP100
0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17429224; hg19: chr4-38857310; API